ACCESSWIRE
24 May 2023, 22:05 GMT+10
MINNEAPOLIS, MN / ACCESSWIRE / May 24, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will participate in the following investor conferences:
About Celcuity
Celcuity is a clinical-stage biotechnology company focused on development of targeted therapies for treatment of multiple solid tumor indications. The company's lead therapeutic candidate is gedatolisib, a potent, pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients. More detailed information about the VIKTORIA-1 study can be found at ClinicalTrials.gov.The company's CELsignia companion diagnostic platform is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from already approved targeted therapies. Further information about Celcuity can be found at Celcuity.com. Follow us on LinkedIn and Twitter.
Contacts:
Celcuity Inc.
Brian Sullivan, [email protected]
Vicky Hahne, [email protected]
(763) 392-0123
ICR Westwicke
Robert Uhl, [email protected]
(619) 228-5886
SOURCE: Celcuity Inc.
Get a daily dose of Salt Lake City Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Salt Lake City Sun.
More InformationPARIS, France: European plane manufacturer Airbus is reported to be close to a record agreement to sell 500 narrow-body jets ...
TRAVERSE CITY, Michigan: DuPont, Chemours and Corteva have reached an agreement to pay $1.18 billion to resolve complaints of causing ...
NEW YORK, New York - U.S. stocks were directionless Tuesday as investors had little to digest ahead of next week's ...
MENLO PARK, California: Facebook parent Meta has said that under a trial that could last through the end of June, ...
WASHINGTON D.C.: The Biden administration is expected to approve a deal allowing General Electric to assemble jet engines in India ...
TAIPEI, Taiwan: Taiwan and the United States are set to sign the first deal under a new trade framework, marking ...
KHARTOUM - Sudan's army has been battling to defend a military industrial complex believed to contain large stocks of weapons ...
The OECD slightly raised its growth outlook for the world economy on Wednesday as inflation eases and China has dropped ...
Los Angeles [US], June 7 (ANI): How time flies! It's been 25 years since 'Sex and the City' premiered and ...
© Provided by Xinhua HEFEI, June 7 (Xinhua) -- The Yangtze River Delta of China will promote high-level opening up, ...
© Provided by Xinhua BEIJING, June 7 (Xinhua) -- China's total imports and exports expanded 4.7 percent year on year ...
Srinagar (Jammu and Kashmir) [India], June 7 (ANI): Born and raised in the HMT area of Srinagar in Jammu and ...